CCL5 and plasma cell myeloma: CCL5/RANTES expression is increased in acute myeloid leukemia cells [185], multiple myeloma cells [165], MDA-MB-231 and MDA-MB-435 breast cancer cells [142,153], cervical squamous carcinoma cells [46], and primary rat astrocytes [202].